Medmal (Medical malpractice)
-
What insurers can learn from the history that led to this deal. -
ProAssurance brands will be transitioned to The Doctors Company in "all/most markets" over time.
-
The Californian insurer is buying the medmal carrier for $25.00 per share, or a ~60% premium.
-
The executive is returning to Tysers after nearly four years at Price Forbes.
-
Profitability over growth continues to be the company’s “mantra”.
-
Frequency has rebounded, while severity has spiked beyond the pre-Covid-19 years.
-
Batch coverage is also coming into focus as insurers look for ways to reduce exposure to large losses.
-
Executives said the company continues to shrink its book of business in markets with poor underwriting conditions.
-
The carrier will only continue to offer lead capacity to some existing accounts.
-
The all-items CPI increased 2.5% over the last 12 months.
-
Increasing loss picks in difficult lines suggest top writers are accepting shifting loss trends.
-
The highest releases in nearly 15 years challenge conventional wisdom on reserving.
